F

Fennec Pharmaceuticals Inc
TSX:FRX

Watchlist Manager
Fennec Pharmaceuticals Inc
TSX:FRX
Watchlist
Price: 10.39 CAD Market Closed
Market Cap: 283.9m CAD

Intrinsic Value

The intrinsic value of one FRX stock under the Base Case scenario is 23.85 CAD. Compared to the current market price of 10.39 CAD, Fennec Pharmaceuticals Inc is Undervalued by 56%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

FRX Intrinsic Value
23.85 CAD
Undervaluation 56%
Intrinsic Value
Price
F
Worst Case
Base Case
Best Case

Valuation History
Fennec Pharmaceuticals Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about FRX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is FRX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Fennec Pharmaceuticals Inc.

Explain Valuation
Compare FRX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about FENC?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Fennec Pharmaceuticals Inc

Current Assets 46.1m
Cash & Short-Term Investments 21.9m
Receivables 19.3m
Other Current Assets 4.8m
Non-Current Assets 3.2m
Other Non-Current Assets 3.2m
Current Liabilities 9.8m
Accounts Payable 5.9m
Accrued Liabilities 3.7m
Other Current Liabilities 248k
Non-Current Liabilities 43.9m
Long-Term Debt 18.2m
Other Non-Current Liabilities 25.7m
Efficiency

Free Cash Flow Analysis
Fennec Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Fennec Pharmaceuticals Inc

Revenue
38.8m USD
Cost of Revenue
-2.7m USD
Gross Profit
36.1m USD
Operating Expenses
-40.8m USD
Operating Income
-4.7m USD
Other Expenses
-2.3m USD
Net Income
-6.9m USD
Fundamental Scores

FRX Profitability Score
Profitability Due Diligence

Fennec Pharmaceuticals Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
Exceptional Gross Margin
ROE is Increasing
42/100
Profitability
Score

Fennec Pharmaceuticals Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

FRX Solvency Score
Solvency Due Diligence

Fennec Pharmaceuticals Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Negative Net Debt
Long-Term Solvency
54/100
Solvency
Score

Fennec Pharmaceuticals Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

FRX Price Targets Summary
Fennec Pharmaceuticals Inc

Wall Street analysts forecast FRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FRX is 19.53 CAD with a low forecast of 18.63 CAD and a high forecast of 22.34 CAD.

Lowest
Price Target
18.63 CAD
79% Upside
Average
Price Target
19.53 CAD
88% Upside
Highest
Price Target
22.34 CAD
115% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Fennec Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for FENC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

FENC Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one FRX stock?

The intrinsic value of one FRX stock under the Base Case scenario is 23.85 CAD.

Is FRX stock undervalued or overvalued?

Compared to the current market price of 10.39 CAD, Fennec Pharmaceuticals Inc is Undervalued by 56%.

Back to Top